Show simple item record

dc.contributor.authorCarrageta, David F.
dc.contributor.authorVan der Walt, Mietha M.
dc.contributor.authorTerre'Blanche, Gisella
dc.contributor.authorDias, Tânia R.
dc.contributor.authorJarak, Ivana
dc.date.accessioned2018-08-30T06:34:43Z
dc.date.available2018-08-30T06:34:43Z
dc.date.issued2018
dc.identifier.citationCarrageta, D.F. et al. 2018. 8-(3-phenylpropyl)-1,3,7-triethylxanthine is a synthetic caffeine substitute with stronger metabolic modulator activity. Toxicology in vitro, 53:114-120. [https://doi.org/10.1016/j.tiv.2018.08.002]en_US
dc.identifier.issn0887-2333
dc.identifier.issn1879-3177 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/30843
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0887233318304314
dc.identifier.urihttps://doi.org/10.1016/j.tiv.2018.08.002
dc.description.abstractCaffeine is one of the most worldwide consumed methylxanthines. It is well-known for its thermogenic and cell metabolism modulating effects. Based on methylxanthines' chemical structure, 8-(3-phenylpropyl)-1,3,7-triethylxanthine (PTX) is a novel adenosine antagonist with higher receptor affinity than caffeine. Therefore, we hypothesized that PTX metabolic effects could be stronger than those of caffeine. For that purpose, murine 3T3-L1 cells were cultured in the presence of increasing doses of PTX or caffeine (0.1, 1, 10 and 100 μM) for 24 h. Cytotoxicity was evaluated by reduction of tetrazolium salt (MTT) and lactate dehydrogenase (LDH) release. Cell metabolites released to the culture medium were identified and quantified by proton nuclear magnetic resonance (1H NMR). Cellular oxidative profile was also evaluated. Our results showed that PTX displayed no signs of cytotoxicity at all studied concentrations. When compared with caffeine, PTX increased glucose, pyruvate, and glutamine consumption, as well as lactate, alanine, and acetate production. Additionally, PTX decreased protein oxidation, thus protecting against oxidative stress-induced damage. These results illustrate that PTX is a stronger and less cytotoxic caffeine substitute with potential applications as metabolic modulator and a good candidate for novel drug designen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subject8-(3-phenylpropyl)-1,3,7-triethylxanthineen_US
dc.subjectCaffeineen_US
dc.subjectGlucose metabolismen_US
dc.subjectMetabolic modulatoren_US
dc.subjectObesityen_US
dc.subjectXanthineen_US
dc.title8-(3-phenylpropyl)-1,3,7-triethylxanthine is a synthetic caffeine substitute with stronger metabolic modulator activityen_US
dc.typeArticleen_US
dc.contributor.researchID13035134 - Van der Walt, Mietha Magdalena
dc.contributor.researchID10206280 - Terre'Blanche, Gisella


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record